Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245.6 EUR | -0.14% |
|
-.--% | -.--% |
25/06 | Halozyme Therapeutics Says Roche's OCREVUS SC With ENHANZE Gets European Commission Approval | MT |
25/06 | Roche: approval of Ocrevus SC in Europe | CF |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ROG Stock
- RHO5 Stock
- Charts Roche Holding AG